ATE476525T1 - Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern - Google Patents

Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern

Info

Publication number
ATE476525T1
ATE476525T1 AT04802347T AT04802347T ATE476525T1 AT E476525 T1 ATE476525 T1 AT E476525T1 AT 04802347 T AT04802347 T AT 04802347T AT 04802347 T AT04802347 T AT 04802347T AT E476525 T1 ATE476525 T1 AT E476525T1
Authority
AT
Austria
Prior art keywords
endometrial
markers
phase
markers associated
methods
Prior art date
Application number
AT04802347T
Other languages
English (en)
Inventor
Terence J Colgan
Michael K W Siu
Alexander D Romaschin
Eric C C Yang
Leroi Desouza
George Diehl
Jingzhong Gou
Original Assignee
Mount Sinai Hospital Corp
Michael K W Siu
Univ Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp, Michael K W Siu, Univ Health Network filed Critical Mount Sinai Hospital Corp
Application granted granted Critical
Publication of ATE476525T1 publication Critical patent/ATE476525T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04802347T 2003-12-23 2004-12-21 Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern ATE476525T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53260103P 2003-12-23 2003-12-23
US63099004P 2004-11-24 2004-11-24
PCT/CA2004/002172 WO2005061725A1 (en) 2003-12-23 2004-12-21 Methods for detecting markers associated with endometrial disease or phase

Publications (1)

Publication Number Publication Date
ATE476525T1 true ATE476525T1 (de) 2010-08-15

Family

ID=34713798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04802347T ATE476525T1 (de) 2003-12-23 2004-12-21 Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern

Country Status (7)

Country Link
US (1) US20080226554A1 (de)
EP (2) EP1711618B1 (de)
AT (1) ATE476525T1 (de)
AU (1) AU2004303448A1 (de)
CA (1) CA2550900A1 (de)
DE (1) DE602004028513D1 (de)
WO (1) WO2005061725A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
DE102005059242A1 (de) 2005-12-12 2007-06-14 Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten Molekulare Marker für eine Tumordiagnose und -therapie
CA2703795A1 (en) 2006-10-27 2008-05-02 Mount Sinai Hospital Endometrial phase or endometrial cancer biomarkers
US8183047B2 (en) * 2007-10-18 2012-05-22 University Of Medicine And Dentistry Of New Jersey Methods of detecting mastitis by levels of proteasomes
DE102007062847A1 (de) * 2007-12-21 2009-12-31 Protagen Ag Markersequenzen für neurodegenerative Erkrankungen und deren Verwendung
US9684001B2 (en) 2008-02-07 2017-06-20 Ranju Ralhan Biomarkers for head-and-neck cancers and precancers
CA2618163A1 (en) * 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
WO2009126969A2 (en) * 2008-04-11 2009-10-15 Expression Pathology Inc. Biomarkers for endometrial disease
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2012019300A1 (en) * 2010-08-10 2012-02-16 Siu K W Michael Endometrial cancer biomarkers and methods of identifying and using same
TWI484183B (zh) * 2011-09-01 2015-05-11 國立成功大學 癌症轉移之評估方法及生物標記、及抑制癌症轉移之ｓｉＲＮＡ化合物
WO2013142155A1 (en) * 2012-03-22 2013-09-26 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
EP2755030A1 (de) * 2013-01-15 2014-07-16 Bergen Teknologioverforing AS Prognosemarker für Endometriumkarzinome
WO2015105190A1 (ja) * 2014-01-10 2015-07-16 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
US11215607B2 (en) * 2014-02-18 2022-01-04 Ono Pharmaceutical Co., Ltd. Biomarker for diagnosis of irritable bowel syndrome
US11129851B2 (en) 2014-06-17 2021-09-28 Igenomix S.L. Stem cell therapy in endometrial pathologies
EP3371605B1 (de) * 2015-11-05 2021-06-23 Vanderbilt University Proteinquantifizierung in multizellulären gewebeproben
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
WO2017180909A1 (en) * 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods
EP4610655A3 (de) * 2016-05-04 2025-12-10 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Marker für endometriumkrebs
US11204355B2 (en) 2017-02-20 2021-12-21 Vanderbilt University Immune checkpoint molecular fitness profiling by mass spectrometry
KR101805430B1 (ko) * 2017-04-26 2017-12-06 (주)넥스젠바이오텍 항산화 활성 및 피부 세포 증식 효과가 증가한 열 충격 단백질의 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물
CN117288953A (zh) * 2017-07-21 2023-12-26 瓦尔德西布伦大学医院基金会研究所 一种子宫内膜癌的预后方法
CN112578123B (zh) * 2019-09-27 2022-10-25 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途
CN112190692B (zh) * 2020-09-30 2023-03-31 复旦大学附属妇产科医院 NrCAM在制备药物中的用途
CN113493839A (zh) * 2021-09-06 2021-10-12 北京泱深生物信息技术有限公司 基因标志物组合在诊断子宫内膜癌中的应用
IT202300002919A1 (it) * 2023-02-21 2024-08-21 Marca Antonio La Nuovo metodo
CN117589989B (zh) * 2023-10-12 2025-03-04 华中科技大学同济医学院附属同济医院 子宫内膜癌保育治疗耐药标志物、产品及应用

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
DE2901218A1 (de) 1979-01-13 1980-07-17 Byk Gulden Lomberg Chem Fab Ung von theophyllin
US4472371A (en) 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4478818A (en) 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4558279A (en) 1983-03-07 1985-12-10 University Of Cincinnati Methods for detecting and imaging a temperature of an object by nuclear magnetic resonance
US4732864A (en) 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
FI874419A7 (fi) 1987-10-08 1989-04-09 Instr Oy Laitteisto ja menetelmä kohteen ominaisuuksien tutkimiseen.
CA1337394C (en) * 1987-11-17 1995-10-24 Nelson N. H. Teng Vaginal sample test and reagents
US5109397A (en) 1988-04-22 1992-04-28 Analogic Corporation X-ray tomography apparatus with lateral movement compensation
US4985678A (en) 1988-10-14 1991-01-15 Picker International, Inc. Horizontal field iron core magnetic resonance scanner
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5103098A (en) 1989-11-09 1992-04-07 Board Of Regents, The University Of Texas System High resolution gamma ray detectors for positron emission tomography (pet) and single photon emission computed tomography (spect)
US5214382A (en) 1990-02-23 1993-05-25 Baylor Research Institute Magnetic resonance imaging with selective contrast enhancement
JPH0449949A (ja) 1990-06-15 1992-02-19 Hitachi Ltd 磁気共鳴サーモグラフィー方法
US5031624A (en) 1990-08-17 1991-07-16 Wisconsin Alumni Research Foundation Phase contrast, line-scanned method for NMR angiography
US5317091A (en) 1991-02-27 1994-05-31 Akzo N.V. Technetium-99m labeling of proteins
US5210421A (en) 1991-06-10 1993-05-11 Picker International, Inc. Simultaneous transmission and emission converging tomography
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5605662A (en) 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5208581A (en) 1991-11-22 1993-05-04 General Electric Company High speed communication apparatus for computerized axial tomography (cat) scanners with matching receiver
JP3160351B2 (ja) 1992-03-13 2001-04-25 株式会社東芝 磁気共鳴診断装置
US5312922A (en) 1992-04-06 1994-05-17 Nordion International Inc. Europium and terbium chelators for time-resolved fluorometric assays
DE69326202T2 (de) 1992-06-29 2000-04-13 Koninklijke Philips Electronics N.V., Eindhoven Verfahren und Gerät zur Kernresonanzabbildung
US5272343A (en) 1992-07-27 1993-12-21 General Electric Company Sorter for coincidence timing calibration in a PET scanner
DE69329873T2 (de) 1992-10-26 2001-09-13 Koninklijke Philips Electronics N.V., Eindhoven Kompensierung von Wirbelströmen in der Bilderzeugung mittels magnetischer Resonanz
FI105293B (fi) 1993-06-08 2000-07-14 Picker Nordstar Oy Magneettikuvaukseen käytettävän magneetin napakenkä
JPH06347555A (ja) 1993-06-10 1994-12-22 Hamamatsu Photonics Kk ポジトロンイメージング装置
US5446799A (en) 1993-11-01 1995-08-29 Picker International, Inc. CT Scanner with improved processing efficiency 180 degrees+ fan angle reconstruction system
US5406479A (en) 1993-12-20 1995-04-11 Imatron, Inc. Method for rebinning and for correcting cone beam error in a fan beam computed tomographic scanner system
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5650135A (en) 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5600145A (en) 1995-01-19 1997-02-04 Picker International, Inc. Emission/transmission device for use with a dual head nuclear medicine gamma camera with the transmission source located behind the emission collimator
DE19506561C1 (de) 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
US5608221A (en) 1995-06-09 1997-03-04 Adac Laboratories Multi-head nuclear medicine camera for dual SPECT and PET imaging with monuniform attenuation correction
US5602891A (en) 1995-11-13 1997-02-11 Beth Israel Imaging apparatus and method with compensation for object motion
SE9602594D0 (sv) 1996-07-01 1996-07-01 Stefan Nilsson Förfarande och anordning vid datortomografi
JP3384944B2 (ja) 1996-07-11 2003-03-10 ジーイー横河メディカルシステム株式会社 Ｍｒｉ装置
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー
GB2319844A (en) 1996-11-28 1998-06-03 Marconi Gec Ltd Prepolarising MRI magnet with powdered iron poles
US5841140A (en) 1997-01-08 1998-11-24 Smv America, Inc. Gamma camera for pet and spect studies
JP3679892B2 (ja) 1997-04-10 2005-08-03 株式会社東芝 磁気共鳴イメージング装置
CN1230120C (zh) 1997-05-23 2005-12-07 普罗里森姆股份有限公司 由mri引导的治疗装置
US5900636A (en) 1997-05-30 1999-05-04 Adac Laboratories Dual-mode gamma camera system utilizing single-photon transmission scanning for attenuation correction of PET data
US5946371A (en) 1997-12-08 1999-08-31 Analogic Corporation Method and apparatus for volumetric computed tomography scanning with offset symmetric or asymmetric detector system
US6119032A (en) 1997-12-31 2000-09-12 U.S. Philips Corporation Method and system for positioning an invasive device by magnetic resonance (MR) imaging of an MR visible device
JP3469551B2 (ja) * 1998-03-05 2003-11-25 ダイアデクスアス・インコーポレーテッド 子宮内膜癌および子宮癌の検出及び監視のための新規な方法
NZ508690A (en) * 1998-06-04 2003-05-30 Reprogen Inc Use of cathepsin S in the diagnosis and treatment of endometriosis
WO1999063116A2 (en) * 1998-06-04 1999-12-09 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
US6121775A (en) 1998-06-16 2000-09-19 Beth Israel Deaconess Medical Center, Inc. MRI imaging method and apparatus
DE69931644T2 (de) * 1998-09-23 2007-05-10 Diadexus, Inc., South San Francisco Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
US6115446A (en) 1999-04-09 2000-09-05 Arch Development Corp. Fast reconstruction of fan-beam CT and SPECT
US7013221B1 (en) 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
WO2001062959A2 (en) * 2000-02-25 2001-08-30 Metriogene Biosciences Inc. Endometriosis-related markers and uses thereof
US6884578B2 (en) * 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
US6649359B2 (en) * 2000-06-01 2003-11-18 The Brigham & Women's Hospital, Inc. Diagnosis of endometrial precancers
CA2703795A1 (en) * 2006-10-27 2008-05-02 Mount Sinai Hospital Endometrial phase or endometrial cancer biomarkers

Also Published As

Publication number Publication date
CA2550900A1 (en) 2005-07-07
EP1711618A4 (de) 2008-05-07
EP2251695A3 (de) 2011-06-22
DE602004028513D1 (de) 2010-09-16
AU2004303448A1 (en) 2005-07-07
WO2005061725A1 (en) 2005-07-07
EP1711618B1 (de) 2010-08-04
EP2251695A2 (de) 2010-11-17
US20080226554A1 (en) 2008-09-18
EP1711618A1 (de) 2006-10-18
EP2251695B1 (de) 2013-07-17

Similar Documents

Publication Publication Date Title
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
CY1110923T1 (el) Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE602004019812D1 (de) Marker für neuromyelitis optica
DE60226941D1 (de) Verfahren zum Prüfen der Haut an mehreren Stellen
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE525649T1 (de) Nachweis von proteinen mit veränderter konformation
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
DE60328055D1 (de) Verfahren zum nachweis von pathogenen mykobakterien in klinischen proben
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE416619T1 (de) Verfahren zur dearomatisierung von molkeprotein
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
DE50115528D1 (de) Verfahren zur identifizierung einer auf einen körper aufgebrachten markierung
ATE449323T1 (de) Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren
DE50204790D1 (de) System und verfahren zum bestimmen der gangauswahl mittels wählhebel
DE60106395D1 (de) Verfahren zum lesen von elektronischen etiketten mittels gleichzeitiger identifizierung ihres kodes
DE60210584T8 (de) Verfahren, vorrichtung und programm zum erhalt von reifeninformation
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
EP1575515A4 (de) Achaete-scute-ähnliche 2 polypeptide und kodierende nukleinsäuren und verfahren zur diagnose und behandlung eines tumors
DE50313133D1 (de) Verfahren zur erkennung von reifeneigenschaften
DE60139314D1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
DE602004021892D1 (de) Verfahren Zum genetischen Test für Blasenkrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties